Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical workflow), End User (Hospital, Labs, Pharma/Biotech), & Region - Global Forecast to 2029

Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical workflow), End User (Hospital, Labs, Pharma/Biotech), & Region - Global Forecast to 2029

The global AI in Pathology market is expected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024 at a high CAGR of 15.4% during the forecast period. AI in pathology refers to the healthcare industry’s sector which comprises of development, deployment, and utilization of Artificial Intelligence (AI) designed for pathology applications specifically. Clinical data, genomic information, and disease progression can be analysed by using these AI models. These AI models assist in personalized treatment planning, identifying high-risk patients, and optimizing healthcare resource allocation. The AI helps and assists pathologists in extracting relevant information and analyzing images with the use of advanced AI algorithms, computer vision, and machine learning.

“The drug discovery segment accounted for the largest share in 2023, by use case.”

In 2023, the drug discovery segment held the largest share of the AI in pathology market. The major factor behind this is the high demand for efficient and cost-effective drugs, as AI in pathology helps in accelerating the drug discovery process by automating the data analytics and identifying potential drug faster. In addition, the advancements in high throughput screenings imaging technologies and utilization of AI in toxicology testing for illicit drugs also act as a driving force for this market. Furthermore, the reduced time and costs play a very vital role as traditional methods are very time consuming and expensive as well, the introduction of AI in pathology helps in streamlining the process by enabling faster insights and decision making. Which in tun makes the process more efficient and cost effective, these all factors combined act as a catalyst for the growth of this market.

“Pharmaceutical and biopharmaceutical companies is the fastest growing end-user segment in the AI in pathology market.”

The pharmaceutical and biopharmaceutical companies segment is projected to witness the highest growth rate during the forecast period. The growing collaboration between pharmaceutical companies and AI providers fuels rapid adoption of AI, also the companies are heavily investing in AI tools to stay competitive in drug development and innovation. As AI helps in fast tracking and streamlining the processes for drug discovery by analysing large datasets, identifying patterns in tissue samples, and predicting treatment responses, which reduces the time consumption and makes it cost effective, leading to faster innovations. The biopharmaceutical companies rely on AI-based digital pathology for majorly development of individualized medicine, as AI powered pathology aids the development of personalised medicine by providing detailed insights into individual portfolio.

“North America accounted for the largest share in 2023, in AI in pathology market.”

In 2023, the North American region held the largest market share in the AI in pathology market due to several factors. The first and foremost being the high adoption of AI technology and strong investment in research and development driving the market growth. For instance, companies like Koninklijke Philips N.V. in 2023, invested nearly USD 895 million in R&D for diagnosis and treatment. On the other hand, the advanced healthcare infrastructre plays a very vital role in this market as there’s a need of high tech machinery such as advanced microscopes and scanners. Morover, the large patient pool and data availability contributes in creating a large database, which can be further used to train the AI for greater accuracy and efficiency. This increasing focus on technoology, patient safety, and quality improvement, combined with technological advancements in medical devices, continues to drive the adoption of AI in pathology market in North America.

The break-down of primary participants is as mentioned below:

By Company Type - Tier 1: 55%, Tier 2: 25%, and Tier 3: 20%

By Designation - C-level: 50%, Director-level: 30%, and Others: 20%

By Region - North America: 40%, Europe: 35%, Asia Pacific: 20%, RoW: 5%

Key Players in the AI in pathology Market

The key players functioning in the AI in pathology market include Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (US), Akoya Biosciences, Inc. (US), Aiforia Technologies Plc (Finland), Indica Labs Inc. (US), OptraScan (US), Ibex Medical Analytics Ltd. (Israel), Mindpeak GmbH (Germany), Tribun Health (France), Techcyte, Inc. (US), Deep Bio Inc. (Korea), Lumea Inc. (US), Visiopharm (Denmark), aetherAI (Taiwan), Aiosyn (Netherlands), Paige AI, Inc. (US), Proscia Inc. (US), PathAI, Inc. (US), Tempus Labs, Inc. (US), Konfoong Biotech International Co., Ltd. (China), DoMore Diagnostics AS (Norway), Verily Life Sciences, LLC (US), deepPath (US), and 4D Path Inc (US).

Research Coverage:

The report analyses the AI in pathology market. It aims to estimate the market size and future growth potential of various market segments based on by offerings, neural networks, use-case, end-user, by functions and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

Analysis of key drivers (Rising strategic collaborations among market players, integration of AI in multiplex imaging, Rising cases of misdiagnoses, AI-augmented telepathology broadening access to specialized pathology services, and technological advancements in deep learning), restraints (High cost of digital pathology systems, the scarcity of AI expertise and unclear regulatory guidelines for medical software, and lack of interoperability with legacy systems), opportunities (Growing demand for personalized medicine, integration of multi-omics data, and predictive analytics for disease Progression) challenges (Lack of sufficient data to train AI algorithms, data privacy, and ethical concerns, interpretability of AI models) influencing the growth of the AI in pathology market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the AI in pathology market.

Market Development: Comprehensive information on the lucrative emerging markets, offering, neural networks, functions, use-case, end-user, and region.

Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the AI in pathology market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the AI in pathology market like Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (US).

Tables List

Table 1 Exchange Rates Utilized For Conversion To Usd

Table 2 Study Assumption Analysis

Table 3 Risk Assessment Analysis

Table 4 Ai In Pathology Market: Role In Ecosystem

Table 5 Regulatory Bodies, Government Agencies, And Other Organizations

Table 6 Us Fda: Medical Device Classification

Table 7 Us: Medical Device Regulatory Approval Process

Table 8 Canada: Medical Device Regulatory Approval Process

Table 9 Europe: Classification Of Ivd Devices

Table 10 Japan: Medical Device Classification Under Pmda

Table 11 China: Classification Of Medical Devices

Table 12 Indicative Pricing Analysis, By Offering

Table 13 Ai In Pathology Market: Porter’s Five Forces Analysis

Table 14 Influence Of Stakeholders On Buying Process Of Ai In Pathology Products (%)

Table 15 Key Buying Criteria For Ai In Pathology Products

Table 16 Unmet Needs For Ai In Pathology Market

Table 17 End-user Expectations For Ai In Pathology Market

Table 18 Ai In Pathology Market: List Of Conferences And Events

Table 19 Import Data For Hs Code 9011, By Country, 2020–2022 (Usd Thousand)

Table 20 Export Data For Hs Code 9011, By Country, 2020–2022 (Usd Thousand)

Table 21 Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 22 Ai In Pathology Market For Offering, By Country,

2022–2029 (Usd Million)

Table 23 Ai In Pathology Market For End-to-end Solutions,

By Country, 2022–2029 (Usd Million)

Table 24 Ai In Pathology Market For Niche-point Solutions,

By Country, 2022–2029 (Usd Million)

Table 25 Ai In Pathology Market For Technology, By Country,

2022–2029 (Usd Million)

Table 26 Ai In Pathology Market For Hardware, By Type, 2022–2029 (Usd Million)

Table 27 Ai In Pathology Market For Hardware, By Country,

2022–2029 (Usd Million)

Table 28 Ai In Pathology Market For Microscopes, By Country,

2022–2029 (Usd Million)

Table 29 Ai In Pathology Market For Scanners, By Country,

2022–2029 (Usd Million)

Table 30 Ai In Pathology Market For Storage Systems,

By Country, 2022–2029 (Usd Million)

Table 31 Ai In Pathology Market, By Neural Networks, 2022–2029 (Usd Million)

Table 32 Ai In Pathology Market For Convolutional Neural Networks,

By Country, 2022–2029 (Usd Million)

Table 33 Ai In Pathology Market For Generative Adversarial Networks,

By Country, 2022–2029 (Usd Million)

Table 34 Ai In Pathology Market For Recurrent Neural Networks,

By Country, 2022–2029 (Usd Million)

Table 35 Ai In Pathology Market For Other Neural Networks,

By Country, 2022–2029 (Usd Million)

Table 36 Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 37 Ai In Pathology Market For Image Analysis, By Country,

2022–2029 (Usd Million)

Table 38 Ai In Pathology Market For Diagnostics, By Country,

2022–2029 (Usd Million)

Table 39 Ai In Pathology Market For Workflow Management,

By Country, 2022–2029 (Usd Million)

Table 40 Ai In Pathology Market For Data Management,

By Country, 2022–2029 (Usd Million)

Table 41 Ai In Pathology Market For Predictive Analytics,

By Country, 2022–2029 (Usd Million)

Table 42 Ai In Pathology Market For Cdss, By Country, 2022–2029 (Usd Million)

Table 43 Ai In Pathology Market For Automated Report Generation,

By Country, 2022–2029 (Usd Million)

Table 44 Ai In Pathology Market For Quality Assurance Tools,

By Country, 2022–2029 (Usd Million)

Table 45 Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 46 Drug Discovery Applications For Ai In Pathology

Table 47 Ai In Pathology Market For Drug Discovery,

By Type, 2022–2029 (Usd Million)

Table 48 Ai In Pathology Market For Drug Discovery,

By Country, 2022–2029 (Usd Million)

Table 49 Ai In Pathology Market For Target Identification & Selection,

By Country, 2022–2029 (Usd Million)

Table 50 Ai In Pathology Market For Target Validation, By Country,

2022–2029 (Usd Million)

Table 51 Ai In Pathology Market For Hit Identification & Prioritization,

By Country, 2022–2029 (Usd Million)

Table 52 Ai In Pathology Market For Hit-to-lead, By Country,

2022–2029 (Usd Million)

Table 53 Ai In Pathology Market For Lead Optimization,

By Country, 2022–2029 (Usd Million)

Table 54 Ai In Pathology Market For Candidate Selection & Validation,

By Country, 2022–2029 (Usd Million)

Table 55 Ai In Pathology Market For Disease Diagnosis & Prognosis,

By Country, 2022–2029 (Usd Million)

Table 56 Ai In Pathology Market For Clinical Workflow,

By Country, 2022–2029 (Usd Million)

Table 57 Ai In Pathology Market For Training & Education,

By Country, 2022–2029 (Usd Million)

Table 58 Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 59 Ai In Pathology Market For Pharmaceutical & Biopharmaceutical Companies, By Country, 2022–2029 (Usd Million)

Table 60 Ai In Pathology Market For Hospitals & Reference Laboratories,

By Country, 2022–2029 (Usd Million)

Table 61 Ai In Pathology Market For Academic & Research Institutes,

By Country, 2022–2029 (Usd Million)

Table 62 Ai In Pathology Market, By Region, 2022–2029 (Usd Million)

Table 63 North America: Ai In Pathology Market, By Country,

2022–2029 (Usd Million)

Table 64 North America: Ai In Pathology Market, By Offering,

2022–2029 (Usd Million)

Table 65 North America: Ai In Pathology Market, By Function,

2022–2029 (Usd Million)

Table 66 North America: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 67 North America: Ai In Pathology Market, By Use Case,

2022–2029 (Usd Million)

Table 68 North America: Ai In Pathology Market, By End User,

2022–2029 (Usd Million)

Table 69 Us: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 70 Us: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 71 Us: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 72 Us: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 73 Us: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 74 Canada: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 75 Canada: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 76 Canada: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 77 Canada: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 78 Canada: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 79 Europe: Ai In Pathology Market, By Country, 2022–2029 (Usd Million)

Table 80 Europe: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 81 Europe: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 82 Europe: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 83 Europe: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 84 Europe: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 85 Uk: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 86 Uk: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 87 Uk: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 88 Uk: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 89 Uk: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 90 Germany: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 91 Germany: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 92 Germany: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 93 Germany: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 94 Germany: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 95 France: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 96 France: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 97 France: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 98 France: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 99 France: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 100 Italy: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 101 Italy: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 102 Italy: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 103 Italy: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 104 Italy: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 105 Spain: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 106 Spain: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 107 Spain: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 108 Spain: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 109 Spain: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 110 Rest Of Europe: Ai In Pathology Market, By Offering,

2022–2029 (Usd Million)

Table 111 Rest Of Europe: Ai In Pathology Market, By Function,

2022–2029 (Usd Million)

Table 112 Rest Of Europe: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 113 Rest Of Europe: Ai In Pathology Market, By Use Case,

2022–2029 (Usd Million)

Table 114 Rest Of Europe: Ai In Pathology Market, By End User,

2022–2029 (Usd Million)

Table 115 Asia Pacific: Ai In Pathology Market, By Country,

2022–2029 (Usd Million)

Table 116 Asia Pacific: Ai In Pathology Market, By Offering,

2022–2029 (Usd Million)

Table 117 Asia Pacific: Ai In Pathology Market, By Function,

2022–2029 (Usd Million)

Table 118 Asia Pacific: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 119 Asia Pacific: Ai In Pathology Market, By Use Case,

2022–2029 (Usd Million)

Table 120 Asia Pacific: Ai In Pathology Market, By End User,

2022–2029 (Usd Million)

Table 121 China: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 122 China: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 123 China: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 124 China: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 125 China: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 126 Japan: Cancer Incidence, By Cancer Type, 2020 Vs. 2040

Table 127 Japan: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 128 Japan: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 129 Japan: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 130 Japan: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 131 Japan: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 132 India: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 133 India: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 134 India: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 135 India: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 136 India: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 137 Rest Of Asia Pacific: Ai In Pathology Market,

By Offering, 2022–2029 (Usd Million)

Table 138 Rest Of Asia Pacific: Ai In Pathology Market,

By Function, 2022–2029 (Usd Million)

Table 139 Rest Of Asia Pacific: Ai In Pathology Market,

By Neural Network, 2022–2029 (Usd Million)

Table 140 Rest Of Asia Pacific: Ai In Pathology Market,

By Use Case, 2022–2029 (Usd Million)

Table 141 Rest Of Asia Pacific: Ai In Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 142 Latin America: Ai In Pathology Market,

By Country, 2022–2029 (Usd Million)

Table 143 Latin America: Ai In Pathology Market,

By Offering, 2022–2029 (Usd Million)

Table 144 Latin America: Ai In Pathology Market,

By Function, 2022–2029 (Usd Million)

Table 145 Latin America: Ai In Pathology Market,

By Neural Network, 2022–2029 (Usd Million)

Table 146 Latin America: Ai In Pathology Market,

By Use Case, 2022–2029 (Usd Million)

Table 147 Latin America: Ai In Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 148 Brazil: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 149 Brazil: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 150 Brazil: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 151 Brazil: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 152 Brazil: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 153 Mexico: Ai In Pathology Market, By Offering, 2022–2029 (Usd Million)

Table 154 Mexico: Ai In Pathology Market, By Function, 2022–2029 (Usd Million)

Table 155 Mexico: Ai In Pathology Market, By Neural Network,

2022–2029 (Usd Million)

Table 156 Mexico: Ai In Pathology Market, By Use Case, 2022–2029 (Usd Million)

Table 157 Mexico: Ai In Pathology Market, By End User, 2022–2029 (Usd Million)

Table 158 Rest Of Latin America: Ai In Pathology Market,

By Offering, 2022–2029 (Usd Million)

Table 159 Rest Of Latin America: Ai In Pathology Market,

By Function, 2022–2029 (Usd Million)

Table 160 Rest Of Latin America: Ai In Pathology Market,

By Neural Network, 2022–2029 (Usd Million)

Table 161 Rest Of Latin America: Ai In Pathology Market,

By Use Case, 2022–2029 (Usd Million)

Table 162 Rest Of Latin America: Ai In Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 163 Middle East & Africa: Ai In Pathology Market,

By Region, 2022–2029 (Usd Million)

Table 164 Middle East & Africa: Ai In Pathology Market,

By Offering, 2022–2029 (Usd Million)

Table 165 Middle East & Africa: Ai In Pathology Market,

By Function, 2022–2029 (Usd Million)

Table 166 Middle East & Africa: Ai In Pathology Market,

By Neural Network, 2022–2029 (Usd Million)

Table 167 Middle East & Africa: Ai In Pathology Market,

By Use Case, 2022–2029 (Usd Million)

Table 168 Middle East & Africa: Ai In Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 169 Gcc Countries: Ai In Pathology Market,

By Offering, 2022–2029 (Usd Million)

Table 170 Gcc Countries: Ai In Pathology Market,

By Function, 2022–2029 (Usd Million)

Table 171 Gcc Countries: Ai In Pathology Market,

By Neural Network, 2022–2029 (Usd Million)

Table 172 Gcc Countries: Ai In Pathology Market,

By Use Case, 2022–2029 (Usd Million)

Table 173 Gcc Countries: Ai In Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 174 Rest Of Middle East & Africa: Ai In Pathology Market,

By Offering, 2022–2029 (Usd Million)

Table 175 Rest Of Middle East & Africa: Ai In Pathology Market,

By Function, 2022–2029 (Usd Million)

Table 176 Rest Of Middle East & Africa: Ai In Pathology Market,

By Neural Network, 2022–2029 (Usd Million)

Table 177 Rest Of Middle East & Africa: Ai In Pathology Market,

By Use Case, 2022–2029 (Usd Million)

Table 178 Rest Of Middle East & Africa: Ai In Pathology Market,

By End User, 2022–2029 (Usd Million)

Table 179 Overview Of Strategies Deployed By Key Companies

Table 180 Ai In Pathology Market: Degree Of Competition

Table 181 Offering Footprint Analysis

Table 182 Use-case Footprint Analysis

Table 183 End-user Footprint Analysis

Table 184 Region Footprint Analysis

Table 185 Ai In Pathology Market: Detailed List Of Key Start-ups/Smes

Table 186 Ai In Pathology Market: Competitive Benchmarking Of Key Emerging Players/Startups

Table 187 Ai In Pathology Market: Product/Service Launches & Approvals, January 2021–october 2024

Table 188 Ai In Pathology Market: Deals, January 2021–october 2024

Table 189 Ai In Pathology Market: Other Developments, 2021–2024

Table 190 Koninklijke Philips N.V.: Company Overview

Table 191 Koninklijke Philips N.V.: Products/Services Offered

Table 192 F. Hoffmann-la Roche Ltd.: Company Overview

Table 193 F. Hoffmann La Roche Ltd.: Products/Services Offered

Table 194 F. Hoffmann-la Roche Ltd.: Product/Service Launches,

January 2021−october 2024

Table 195 F. Hoffmann-la Roche Ltd.: Deals, January 2021−october 2024

Table 196 Hologic, Inc.: Company Overview

Table 197 Hologic, Inc.: Products/Services Offered

Table 198 Hologic, Inc.: Product/Service Approvals, January 2021−october 2024

Table 199 Akoya Biosciences, Inc.: Company Overview

Table 200 Akoya Biosciences, Inc.: Product/Services Offered

Table 201 Akoya Biosciences Inc.: Deals, January 2021−october 2024

Table 202 Aiforia Technologies Plc: Company Overview

Table 203 Aiforia Technologies Plc: Product/Services Offered

Table 204 Aiforia Technologies Plc: Deals, January 2021−october 2024

Table 205 Indica Labs Inc.: Company Overview

Table 206 Indica Labs Inc.: Products/Services Offered

Table 207 Indica Labs Inc.: Product/Service Launches & Approvals,

January 2021−october 2024

Table 208 Indica Labs Inc.: Deals, January 2021−october 2024

Table 209 Indica Labs Inc.: Expansions, January 2021–october 2024

Table 210 Optrascan: Company Overview

Table 211 Optrascan: Products/Services Offered

Table 212 Optrascan: Other Developments, January 2021–october 2024

Table 213 Ibex Medical Analytics Ltd.: Company Overview

Table 214 Ibex Medical Analytics Ltd.: Products/Services Offered

Table 215 Ibex Medical Analytics Ltd.: Product/Service Launches/Approvals, January 2021–october 2024

Table 216 Ibex Medical Analytics Ltd: Deals, January 2021–october 2024

Table 217 Mindpeak Gmbh: Company Overview

Table 218 Mindpeak Gmbh: Products/Services Offered

Table 219 Mindpeak Gmbh: Product/Service Approvals,

January 2021–october 2024

Table 220 Mindpeak Gmbh: Deals, January 2021–october 2024

Table 221 Mindpeak Gmbh: Other Developments, January 2021–october 2024

Table 222 Tribun Health: Company Overview

Table 223 Tribun Health: Products/Services Offered

Table 224 Tribun Health: Deals, January 2021–october 2024

Table 225 Techcyte, Inc.: Company Overview

Table 226 Techcyte, Inc.: Products/Services Offered

Table 227 Techcyte, Inc.: Product/Service Launches, January 2021–october 2024

Table 228 Techcyte, Inc.: Deals, January 2021–october 2024

Table 229 Techcyte, Inc.: Other Developments, January 2021–october 2024

Table 230 Deep Bio Inc.: Company Overview

Table 231 Deep Bio Inc.: Products/Services Offered

Table 232 Deep Bio Inc.: Deals, January 2021–october 2024

Table 233 Lumea Inc.: Company Overview

Table 234 Lumea Inc.: Products/Services Offered

Table 235 Lumea Inc.: Deals, January 2021–october 2024

Table 236 Visiopharm: Company Overview

Table 237 Visiopharm: Products/Services Offered

Table 238 Visiopharm: Product Launches, January 2021–october 2024

Table 239 Visiopharm: Expansions, January 2021–october 2024

Table 240 Aetherai: Company Overview

Table 241 Aetherai: Products/Services Offered

Table 242 Aetherai: Deals, January 2021–october 2024

Table 243 Aiosyn: Company Overview

Table 244 Aiosyn: Products/Services Offered

Table 245 Aiosyn: Product/Service Launches, January 2021–october 2024

Table 246 Aiosyn: Deals, January 2021–october 2024

Table 247 Aiosyn: Other Developments, January 2021–october 2024

Table 248 Paige Ai, Inc.: Company Overview

Table 249 Paige Ai, Inc.: Products/Services Offered

Table 250 Paige Ai, Inc.: Product/Service Launches & Approvals,

January 2021–october 2024

Table 251 Paige Ai, Inc.: Deals, January 2021–october 2024

Table 252 Paige Ai, Inc.: Other Developments, January 2021–october 2024

Table 253 Proscia, Inc.: Company Overview

Table 254 Proscia, Inc.: Products/Services Offered

Table 255 Proscia, Inc.: Product/Service Launches & Enhancements,

January 2021–october 2024

Table 256 Proscia, Inc.: Deals, January 2021–october 2024

Table 257 Proscia, Inc.: Other Developments, January 2021–october 2024

Table 258 Pathai, Inc.: Company Overview

Table 259 Pathai, Inc.: Products/Services Offered

Table 260 Pathai, Inc.: Product/Service Launches & Approvals,

January 2021–october 2024

Table 261 Pathai, Inc.: Deals, January 2021–october 2024

Table 262 Tempus Labs, Inc.: Company Overview

Table 263 Tempus Labs, Inc.: Products/Services Offered

Table 264 Tempus Labs, Inc.: Product/Service Launches,

January 2021–october 2024

Table 265 Konfoong Bioinformation Tech Co., Ltd.: Company Overview

Table 266 Domore Diagnostics As: Company Overview

Table 267 Verily Life Sciences, Llc: Company Overview

Table 268 Deeppath: Company Overview

Table 269 4d Path Inc.: Company Overview

Figures List

Figure 1 Research Design

Figure 2 Primary Sources

Figure 3 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region

Figure 4 Market Size Estimation: Revenue Share Analysis

Figure 5 Ai In Pathology Market: Revenue Share Analysis Illustration

Figure 6 Bottom-up Approach: End-user Spending On Ai In Pathology

Figure 7 Ai In Pathology Market: Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges (2024–2029)

Figure 8 Cagr Projections: Supply-side Analysis

Figure 9 Top-down Approach

Figure 10 Data Triangulation Methodology

Figure 11 Ai In Pathology Market, By Offering, 2024 Vs. 2029 (Usd Million)

Figure 12 Ai In Pathology Market, By Neural Network, 2024 Vs. 2029 (Usd Million)

Figure 13 Ai In Pathology Market, By Use Case, 2024 Vs. 2029 (Usd Million)

Figure 14 Ai In Pathology Market, By End User, 2024 Vs. 2029 (Usd Million)

Figure 15 Ai In Pathology Market: Geographic Snapshot

Figure 16 Development Of Cnns And Ai Learning Models To Propel Market

Figure 17 North America To Dominate Market During Forecast Period

Figure 18 Pharmaceutical & Biopharmaceutical Companies In China Accounted For Largest Market Share In 2023

Figure 19 Us To Register Highest Growth Rate During Forecast Period

Figure 20 Ai In Pathology Market: Drivers, Restraints, Opportunities,

And Challenges

Figure 21 Healthcare Breaches Reported To Us Department Of Health And

Human Services (September 2024)

Figure 22 Ai In Pathology Market: Trends/Disruptions Impacting Customers’ Businesses

Figure 23 Ecosystem Analysis

Figure 24 Value Chain Analysis

Figure 25 Europe: Ivdr Timeline

Figure 26 There Is Moderate-to-high Competitive Intensity Among Market Players

Figure 27 Number Of Patents Published, January 2015−october 2024

Figure 28 Top Applicants & Owners (Companies/Institutions) For Ai In Pathology Patents (January 2015 To May 2024)

Figure 29 Influence Of Stakeholders On Buying Process

Of Ai In Pathology Products

Figure 30 Key Buying Criteria For Ai In Pathology Products

Figure 31 Funding Activities In Ai In Pathology Market

Figure 32 Market Potential Of Ai/Generative Ai In Pathology

Figure 33 North America: Ai In Pathology Market Snapshot

Figure 34 Asia Pacific: Ai In Pathology Market Snapshot

Figure 35 Revenue Analysis Of Key Players For Ai In Pathology Market, 2019−2023

Figure 36 Ai In Pathology Market: Market Share Analysis (2023)

Figure 37 Ai In Pathology Market: Company Evaluation Matrix (Key Players), 2023

Figure 38 Ai In Pathology Market: Company Footprint

Figure 39 Ai In Pathology Market: Company Evaluation Matrix

(Startups/Smes), 2023

Figure 40 Year-to-date (Ytd) Price Total Return And 5-year Stock

Beta Of Life Science Analytics Vendors

Figure 41 Ev/Ebitda Of Key Vendors

Figure 42 Ai In Pathology Market: Brand/Product Comparison Analysis

Figure 43 Koninklijke Philips N.V.: Company Snapshot (2023)

Figure 44 F. Hoffmann-la Roche Ltd.: Company Snapshot (2023)

Figure 45 Hologic, Inc.: Company Snapshot (2023)

Figure 46 Akoya Biosciences, Inc.: Company Snapshot (2023)

Figure 47 Aiforia Technologies Plc: Company Snapshot (2023)